Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 12, 2022

SELL
$55.7 - $145.79 $6,294 - $16,474
-113 Closed
0 $0
Q4 2021

Feb 15, 2022

BUY
$135.05 - $182.59 $13,910 - $18,806
103 Added 1030.0%
113 $17,000
Q2 2021

Aug 17, 2021

SELL
$134.22 - $202.37 $31,407 - $47,354
-234 Reduced 95.9%
10 $2,000
Q4 2020

Mar 10, 2021

BUY
$126.47 - $163.7 $3,414 - $4,419
27 Added 12.44%
244 $35,000
Q3 2020

Dec 21, 2020

BUY
$87.44 - $125.0 $18,974 - $27,125
217 New
217 $27,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.54B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Hm Payson & CO Portfolio

Follow Hm Payson & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.